Skip Navigation LinksHome > October 2012 - Volume 34 - Issue 7 > Late-onset Blueberry Muffin Lesions Following Recombinant Er...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3182678f1e
Clinical and Laboratory Observations

Late-onset Blueberry Muffin Lesions Following Recombinant Erythropoietin Administration in a Premature Infant

Pandey, Vishal MD; Dummula, Krishna MD, MPH; Fraga, Garth MD; Parimi, Prabhu MD

Collapse Box


Recombinant erythropoietin is being used in premature population for anemia of prematurity. It is considered very safe in this population, although risks are still being evaluated. We report the first case of dermal erythropoiesis as a side effect of recombinant erythropoietin in an extremely prematurely born infant presenting with late-onset blueberry muffin lesions.

Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.